Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique

Gosset, Marie; Gal, Jocelyn; Schiappa, Renaud; Dejode, M.; Fouché, Yves; Alazet, Fanny; Roux, Emilie Le; Delpech, Y.; Barranger, Emmanuel

doi:10.1016/j.bulcan.2020.10.013

Cited by 8 publications

(15 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 47 indicators were identified from 14 articles [35,42,44,52,55,60,65,90,91,93,96,106,110,111] regarding the outpatient care of patients diagnosed with cancer. Of these indicators, 46 (93%) showed a decrease in the number of outpatient visits (in Korea, US, France, UK, Spain, Slovenia, and Italy).…”

Section: Resultsmentioning

confidence: 99%

“…With respect to systemic anticancer therapy, 43 indicators were identified from 9 articles [42,53,55,72,96,106,111,139,140], concerning Italy, France, UK, Spain, and the US. The majority (n=40, 93%) showed a decrease in requests for initial treatment and in the number of chemotherapy administrations.…”

Section: Resultsmentioning

confidence: 99%

“…The following stage of the care pathway reported on is cancer treatment. A total of 41 indicators (from 9 articles [35,60,65,72,91,96,103,106,107]) reported on the "number of cancer patients' referrals". Most of the indicators (37, 90%) signalled a decrease in the number of first encounters for oncological examination, namely in Slovenia, UK, US, France, Spain, and the Netherlands.…”

Section: Discussionmentioning

confidence: 99%

“…Regarding "delay in treatment", a total of 42 indicators from 18 articles [39,52,72,77,81,89,91,92,96,97,99,101,138,[142][143][144][145][146] were identified. Of those, 18 (43%) reported an increasing trend in waiting time to treatment, namely in France, Portugal, Canada, US, and Italy.…”

Section: Discussionmentioning

confidence: 99%

“…[35,42,44,52,55,60,65,90,91,93,96,106,110,111] regarding the outpatient care of patients diagnosed with cancer. Of these indicators, 46 (93%) showed a decrease in the number of outpatient visits (in Korea,…”

mentioning

confidence: 99%

See 4 more Smart Citations

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Carvalho

Fernandes

Lange

et al. 2022

Preprint

View full text Add to dashboard Cite

Objectives: Summarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020), and to assess changes in the quality of care as assessed via selected indicators. Methods: Scoping review. Indicators and their reported trends were collated following the cancer care pathway. Results: Database searches retrieved 6277 articles, 838 articles met the inclusion criteria, and 135 articles were included after full-text screening, from which 917 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n=30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n=64, 58%) and in the diagnoses (n=130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed an increasing trend (n=8, 89% and n=14, 56%, respectively). Nine indicators (64%) showed stability in cancer stages distribution. A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n=9), and 70% (n=43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures: 79% (n=82) of indicators concerning surgeries, 72% (n=41) of indicators assessing trends in radiotherapy, and 93% (n=40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported: 64% (n=195) of indicators revealed changes in treatment. Ten indicators (83%) signalled a decreasing number of hospital admissions. Conclusion: Health systems struggled to ensure continuity of cancer care. As this pandemic keeps evolving, the trends reported over the first 6 months of 2020 provide an argument to monitor these changes closely. This information needs to be transparent, standardised, and timely, allowing to monitor quality and outcomes of care during crises and inform policy responses.

show abstract